97 related articles for article (PubMed ID: 21498277)
1. Fluorine-18-fluorodeoxyglucose PET/CT for the evaluation of suspected recurrent uterine leiomyosarcomas.
Kao YH; Saad U; Tan AE; Magsombol BM; Padhy AK
Acta Radiol; 2011 May; 52(4):463-6. PubMed ID: 21498277
[TBL] [Abstract][Full Text] [Related]
2. Fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging of uterine leiomyosarcomas: 2 cases report.
Zhang HJ; Zhan FH; Li YJ; Sun HR; Bai RJ; Gao S
Chin Med J (Engl); 2011 Jul; 124(14):2237-40. PubMed ID: 21933635
[TBL] [Abstract][Full Text] [Related]
3. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
4. Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for the detection of skeletal muscle and skin metastases in uterine leiomyosarcoma: a case report.
Ozdemir E; Poyraz NY; Uzun B; Türkölmez S
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):257-9. PubMed ID: 23153988
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
[TBL] [Abstract][Full Text] [Related]
6. In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.
Wild D; Eyrich GK; Ciernik IF; Stoeckli SJ; Schuknecht B; Goerres GW
J Craniomaxillofac Surg; 2006 Jan; 34(1):9-16. PubMed ID: 16343913
[TBL] [Abstract][Full Text] [Related]
7. Clinical use of combined positron emission tomography and computed tomography in thymoma recurrence.
El-Bawab HY; Abouzied MM; Rafay MA; Hajjar WM; Saleh WM; Alkattan KM
Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):395-9. PubMed ID: 20639307
[TBL] [Abstract][Full Text] [Related]
8. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level.
Lee JH; Park SG; Jee KN; Park DG; Namgung H; Song IH
Nucl Med Commun; 2010 Jun; 31(6):576-82. PubMed ID: 20216474
[TBL] [Abstract][Full Text] [Related]
9. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
10. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
11. Prolapsed endometrial cancer: FDG PET/CT findings.
Kaneta T; Hakamatsuka T; Yamada T; Sato A; Higano S; Fukuda H; Takahashi S; Yamada S
Clin Nucl Med; 2006 Mar; 31(3):180. PubMed ID: 16495748
[No Abstract] [Full Text] [Related]
12. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
Freudenberg LS; Schueler AO; Beyer T; Antoch G; Kühl H; Bornfeld N; Bockisch A; Egelhof T
Surv Ophthalmol; 2004; 49(5):537-40. PubMed ID: 15325198
[TBL] [Abstract][Full Text] [Related]
13. Multiple leiomyosarcoma foci in 18F-FDG PET-CT.
Sürücü E; Aslan M; Karahan P; Durak H
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):269-70. PubMed ID: 23122743
[No Abstract] [Full Text] [Related]
14. [Positron emission tomography with 18F-fluorodeoxyglucose in patients with uterine sarcoma].
Rebollo Aguirre AC; Ramos Font C; Bellón Guardia ME; Cabello García D; Gallego Peinado M; Rodríguez Fernández A; Llamas Elvira JM
Rev Esp Med Nucl; 2007; 26(4):189-95. PubMed ID: 17662185
[TBL] [Abstract][Full Text] [Related]
15. Bone and peritoneal metastasis of breast carcinoma: findings on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Ozcan Kara P; Kara T; Kara Gedik G; Sari O
Rev Esp Med Nucl; 2011; 30(3):180-1. PubMed ID: 21334777
[No Abstract] [Full Text] [Related]
16. Whole-body positron emission tomography with F-18 fluorodeoxyglucose for the detection of recurrence in uterine sarcomas.
Murakami M; Tsukada H; Shida M; Watanabe M; Maeda H; Koido S; Hirasawa T; Muramatsu T; Miyamoto T; Nasu S; Yasuda S; Kajiwara H; Yasuda M; Ide M
Int J Gynecol Cancer; 2006; 16(2):854-60. PubMed ID: 16681773
[TBL] [Abstract][Full Text] [Related]
17. Value of 18F-FDG PET/CT imaging in the staging, restaging, monitoring of response to therapy and surveillance of uterine leiomyosarcomas.
Bélissant O; Champion L; Thevenet H; Weinmann P; Alberini JL
Nucl Med Commun; 2018 Jul; 39(7):652-658. PubMed ID: 29683931
[TBL] [Abstract][Full Text] [Related]
18. FDG PET/CT findings of thyrotoxicosis induced thymic hyperplasia associated to interferon.
Gedik GK; Sarı O; Kaya B; Varoğlu E
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):207-8. PubMed ID: 23036823
[No Abstract] [Full Text] [Related]
19. High 18F-FDG uptake for uterine smooth muscle tumor of uncertain malignant potential.
Zhang R; Tian X; Qin L; Lu D; Shen J
Clin Nucl Med; 2015 Apr; 40(4):349-51. PubMed ID: 25674868
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging.
Umesaki N; Tanaka T; Miyama M; Kawamura N; Ogita S; Kawabe J; Okamura T; Koyama K; Ochi H
Gynecol Oncol; 2001 Mar; 80(3):372-7. PubMed ID: 11263934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
